Literature DB >> 9360978

Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain.

L Oligino1, F D Lung, L Sastry, J Bigelow, T Cao, M Curran, T R Burke, S Wang, D Krag, P P Roller, C R King.   

Abstract

Critical intracellular signals in normal and malignant cells are transmitted by the adaptor protein Grb2 by means of its Src homology 2 (SH2) domain, which binds to phosphotyrosyl (pTyr) residues generated by the activation of tyrosine kinases. To understand this important control point and to design inhibitors, previous investigations have focused on the molecular mechanisms by which the Grb2 SH2 domain selectively binds pTyr containing peptides. In the current study, we demonstrate that the Grb2 SH2 domain can also bind in a pTyr independent manner. Using phage display, an 11-amino acid cyclic peptide, G1, has been identified that binds to the Grb2 SH2 domain but not the src SH2 domain. Synthetic G1 peptide blocks Grb2 SH2 domain association (IC50 10-25 microM) with a 9-amino acid pTyr-containing peptide derived from the SHC protein (pTyr317). These data and amino acid substitution analysis indicate that G1 interacts in the phosphopeptide binding site. G1 peptide requires a YXN sequence similar to that found in natural pTyr-containing ligands, and phosphorylation of the tyrosine increases G1 inhibitory activity. G1 also requires an internal disulfide bond to maintain the active binding conformation. Since the G1 peptide does not contain pTyr, it defines a new type of SH2 domain binding motif that may advance the design of Grb2 antagonists.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360978     DOI: 10.1074/jbc.272.46.29046

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Src-class kinases act within the agrin/MuSK pathway to regulate acetylcholine receptor phosphorylation, cytoskeletal anchoring, and clustering.

Authors:  A S Mohamed; K A Rivas-Plata; J R Kraas; S M Saleh; S L Swope
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Specificity and affinity motifs for Grb2 SH2-ligand interactions.

Authors:  Helmut W H G Kessels; Alister C Ward; Ton N M Schumacher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

3.  Peptide bicycles that inhibit the Grb2 SH2 domain.

Authors:  Justin S Quartararo; Pianpian Wu; Joshua A Kritzer
Journal:  Chembiochem       Date:  2012-06-11       Impact factor: 3.164

4.  In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation.

Authors:  Jason G Weinger; Pouyan Gohari; Ying Yan; Jonathan M Backer; Brian Varnum; Bridget Shafit-Zagardo
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

Review 5.  Phosphotyrosine isosteres: past, present and future.

Authors:  Robert A Cerulli; Joshua A Kritzer
Journal:  Org Biomol Chem       Date:  2019-11-28       Impact factor: 3.876

Review 6.  Bicyclic Peptides as Next-Generation Therapeutics.

Authors:  Curran A Rhodes; Dehua Pei
Journal:  Chemistry       Date:  2017-07-27       Impact factor: 5.236

7.  Syk Is Recruited to Stress Granules and Promotes Their Clearance through Autophagy.

Authors:  Mariya O Krisenko; Reneé L Higgins; Soumitra Ghosh; Qing Zhou; Joy S Trybula; Wen-Horng Wang; Robert L Geahlen
Journal:  J Biol Chem       Date:  2015-10-01       Impact factor: 5.157

8.  A bicyclic peptide scaffold promotes phosphotyrosine mimicry and cellular uptake.

Authors:  Justin S Quartararo; Matthew R Eshelman; Leila Peraro; Hongtao Yu; James D Baleja; Yu-Shan Lin; Joshua A Kritzer
Journal:  Bioorg Med Chem       Date:  2014-10-02       Impact factor: 3.641

9.  Discovery of thioether-bridged cyclic pentapeptides binding to Grb2-SH2 domain with high affinity.

Authors:  Sheng Jiang; Chenzhong Liao; Lakshman Bindu; Biaolin Yin; Karen W Worthy; Robert J Fisher; Terrence R Burke; Marc C Nicklaus; Peter P Roller
Journal:  Bioorg Med Chem Lett       Date:  2009-03-29       Impact factor: 2.823

10.  Novel nonphosphorylated peptides with conserved sequences selectively bind to Grb7 SH2 domain with affinity comparable to its phosphorylated ligand.

Authors:  Dan Zhang; Chen Shao; Siqi Hu; Sucan Ma; Youhe Gao
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.